Skip to contentSkip to Braille Studio

Library / Laws / 118th Congress / House Bills / H.R. 5429

H.R. 5429

To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.

Print stageDateSize⠃
Introduced in House2023-09-139.9K⠃⠗⠋